The US Food and Drug Administration (FDA) has approved a generic form of the drug Truvada, an antiretroviral and pre-exposure prophylaxis (PrEP) from Gilead Sciences. Truvada, also used in HIV treatment in combination with other medications, is a mix of emtricitabine and tenofovir disoproxil fumarate. "The generic manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs". Currently, the wholesale price for a month's worth of Truvada is $1415. The only difference between the generic and Truvada will be the cost and reportedly a variation on its famous powder-blue color.
Arab states issue Qatar 'terror list'
It was unclear how Trump's broadside against Qatar might affect the US-led coalition fighting IS. Like many Arab governments, Qatar has a history of viewing Iran as an arch-rival in the region.
However, just when the generic will be available isn't certain. "Usually, it takes several generics before full cost-savings potential is reached though".
What remains unclear is what exclusivity the FDA is giving Teva to produce generic Truvada.
Several Cavs Players Pissed Off at Warriors Guard Stephen Curry
Through three NBA Finals games, Curry is averaging 28.7 points, 9.7 rebounds and 9.0 assists per contest. If he did intend for it to be as suggestive as some would think, the Cavaliers weren't fond of it.
ACT UP and Treatment Action Group veteran Peter Staley is concerned there will be a backlash of sorts.
In any case, the approval is welcome news, Warren told Medscape. "We've seen momentum for PrEP programs and policies". While Gilead offers an assistance program for uninsured patients and a co-pay assistance program for Truvada, many have cited its cost, which is around $1,500 a month in the U.S., as a barrier to access. "Having a lower-cost alternative will only increase that momentum". "They must maintain these programs, and Teva must establish equivalent or better assistance programs for their generic version".
Trump election-fraud official running for Kansas governor
They argued that Kansas has done little to control its spending a point many Democrats and GOP moderates disputed. Mr Brownback is the poster boy for Laffer-curve enthusiasts who believe that lower taxes always boost growth.
- London attacks: Two of the three killers identified
- Apple's HomePod puts Siri in living rooms
- Comey to Testify on Conversations With Trump
- Qatari blacklist not an 'escalation' of crisis, UAE official says
- (CMCSA) Position Boosted by Parsec Financial Management Inc
- Finisar Corporation (FNSR) EPS Estimated At $0.42
- Andy Murray faces Stan Wawrinka in French Open semifinals
- Zhang Ziyi cast in Godzilla: King of the Monsters
- Injured All Black Coles a series doubt, admits Hansen
- Apple's official video introduction of the HomePod